Avenue Therapeutics, Inc. Stock
Stocks
ATXI
US05360L4032
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
03:42:33 27/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 0.4122 USD | +7.08% |
|
-4.12% | -39.39% |
| Market Cap | 1.36M 1.21M 1.12M 1.02M 1.9M 129M 1.94M 13.52M 5.35M 67.59M 5.1M 4.99M 214M | P/E 2024 |
-0.22x | P/E 2025 | -0.73x |
|---|---|---|---|---|---|
| Enterprise Value | -1.5M -1.34M -1.24M -1.12M -2.1M -142M -2.13M -14.9M -5.89M -74.48M -5.62M -5.5M -236M | EV / Sales 2024 |
-
| EV / Sales 2025 | -491,128x |
| Free-Float |
86.49% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +7.08% | ||
| 1 week | -4.12% | ||
| Current month | +3.08% | ||
| 1 month | -17.54% | ||
| 3 months | +49.59% | ||
| 6 months | -37.53% | ||
| Current year | -39.39% |
| 1 week | 0.38 |  | 0.41 |
| 1 month | 0.27 | | 0.49 |
| Current year | 0.15 | | 0.9 |
| 1 year | 0.15 | | 0.97 |
| 3 years | 0.15 | | 29.25 |
| 5 years | 0.15 | | 2,081.25 |
| 10 years | 0.15 | | 13,882.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 59 | 01/08/2022 | |
David Jin
CEO | Chief Executive Officer | 36 | 31/03/2022 |
Jaclyn Jaffe
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 09/02/2015 | |
Neil Herskowitz
BRD | Director/Board Member | 69 | 01/08/2015 |
Jay Kranzler
CHM | Chairman | 68 | 07/03/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/1/26 | Free | Company | 111,209 | 3.4934% | ||
| 31/3/25 | Free | Company | 33,724 | 1.6419% | ||
| 31/12/24 | Other | Company | 294,800 | 15.4214% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.08% | -4.12% | -41.95% | -98.42% | 1.36M | |
| +0.88% | -0.34% | +40.64% | +73.05% | 65.28B | |
| -0.26% | +6.91% | +11.14% | +77.36% | 54.57B | |
| +0.47% | +3.52% | +8.22% | +100.95% | 53.59B | |
| -2.06% | +2.90% | +24.07% | +48.36% | 45.03B | |
| -1.79% | +0.19% | +19.32% | +123.62% | 42.17B | |
| -1.65% | +0.96% | +237.56% | +823.66% | 39.42B | |
| -2.26% | -4.14% | +15.38% | +45.53% | 32.71B | |
| -3.27% | -11.05% | +19.42% | -6.76% | 24.01B | |
| +12.10% | +16.60% | +55.14% | +46.15% | 26.5B | |
| Average | +0.95% | +2.14% | +38.89% | +123.35% | 38.33B | |
| Weighted average by Cap. | +0.03% | +2.27% | +45.38% | +148.21% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 1.4 1.26 1.16 1.05 1.97 133.58 2 13.98 5.53 69.87 5.27 5.16 221.21 |
| Net income | -11.65M -10.42M -9.64M -8.73M -16.34M -1.11B -16.6M -116M -45.88M -580M -43.73M -42.8M -1.84B | -2.91M -2.6M -2.41M -2.18M -4.08M -277M -4.15M -28.96M -11.46M -145M -10.92M -10.68M -458M |
| Net Debt | -2.59M -2.32M -2.15M -1.94M -3.64M -247M -3.7M -25.82M -10.21M -129M -9.74M -9.53M -409M | -2.86M -2.55M -2.36M -2.14M -4M -272M -4.07M -28.42M -11.24M -142M -10.72M -10.49M -450M |
Employees
1
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/10/26 | USD 0.4123 | +7.08% | 10,999 |
| 23/10/26 | USD 0.3850 | -4.75% | 234 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATXI Stock
Select your edition
All financial news and data tailored to specific country editions
